GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
US Stock MarketDetailed Quotes
ADXS Ayala Pharmaceuticals
- 0.028500
- 0.0000000.00%
15min DelayClose Jan 23 16:00 ET
1.21MMarket Cap0.00P/E (TTM)
0.000000High0.000000Low60Volume0.030000Open0.028500Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)42.59MShares1.49000052wk High-0.05P/B515.87KFloat Cap0.00120052wk Low--Dividend TTM18.10MShs Float187499.985000Historical High--Div YieldTTM0.00%Amplitude0.001200Historical Low0.000000Avg Price1Lot Size
Ayala Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -98.12%13K | 0 | 0 | -76.32%9K | -80.26%692K | 105K | -85.44%91K | -95.01%38K | -52.98%458K | -5.45%3.51M |
| Operating revenue | -98.12%13K | --0 | --0 | -76.32%9K | -80.26%692K | --105K | -85.44%91K | -95.01%38K | -52.98%458K | -5.45%3.51M |
| Cost of revenue | -97.84%13K | 0 | 0 | -76.32%9K | -82.83%602K | 105K | -85.44%91K | -95.01%38K | -62.22%368K | -5.45%3.51M |
| Gross profit | 0 | 0 | 0 | 0 | 90K | 0 | 0 | 0 | 90K | 0 |
| Operating expense | -3.53%36.27M | -9.72%8.78M | -29.26%7.13M | 8.07%8.49M | -4.14%37.59M | 9.73M | 5.37%10.08M | -26.32%7.85M | 7.76%9.94M | 31.71%39.22M |
| Selling and administrative expenses | 25.08%12.19M | 56.31%3.37M | -49.74%1.45M | 21.61%2.76M | 5.01%9.74M | --2.16M | 31.07%2.88M | -10.41%2.27M | 5.99%2.44M | 25.86%9.28M |
| -General and administrative expense | 25.08%12.19M | 56.31%3.37M | -49.74%1.45M | 21.61%2.76M | 5.01%9.74M | --2.16M | 31.07%2.88M | -10.41%2.27M | 5.99%2.44M | 25.86%9.28M |
| Research and development costs | -13.54%24.08M | -28.52%5.41M | -21.06%5.68M | 2.56%5.72M | -6.98%27.85M | --7.57M | -2.29%7.2M | -31.29%5.58M | 8.35%7.5M | 33.63%29.94M |
| Operating profit | 3.30%-36.27M | 9.72%-8.78M | 29.26%-7.13M | -8.07%-8.49M | 4.37%-37.5M | -9.73M | -5.37%-10.08M | 26.32%-7.85M | -6.78%-9.85M | -31.71%-39.22M |
| Net non-operating interest income expense | -21,340.54%-15.72M | -47,948.48%-15.79M | -14,400.00%-143K | -104.76%-86K | 128.46%74K | 33K | 101.59%1K | -90.91%-42K | 117.39%16K | -564.29%-260K |
| Non-operating interest income | -62.16%28K | ---- | ---- | ---- | --74K | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | --15.75M | ---- | ---- | 104.76%86K | --0 | ---- | ---- | 90.91%42K | ---- | --260K |
| Total other finance cost | ---- | ---- | 14,400.00%143K | ---- | ---- | ---- | -101.59%-1K | ---- | -117.39%-16K | ---- |
| Other net income (expense) | ||||||||||
| Income before tax | -38.89%-51.98M | -153.51%-24.57M | 27.83%-7.27M | -8.59%-8.57M | 5.19%-37.43M | -9.69M | -4.67%-10.08M | 26.08%-7.89M | -5.56%-9.84M | -32.83%-39.48M |
| Income tax | -769.86%-3.91M | 37.33%103K | -38.68%65K | -40.65%127K | -24.74%584K | 75K | -36.53%106K | 32.10%214K | -23.79%189K | 82.59%776K |
| Net income | -26.46%-48.07M | -152.62%-24.67M | 27.94%-7.34M | -7.29%-8.7M | 5.57%-38.01M | -9.77M | -3.97%-10.19M | 25.21%-8.11M | -4.80%-10.03M | -33.53%-40.25M |
| Net income continuous Operations | -26.46%-48.07M | -152.62%-24.67M | 27.94%-7.34M | -7.29%-8.7M | 5.57%-38.01M | ---9.77M | -3.97%-10.19M | 25.21%-8.11M | -4.80%-10.03M | -33.53%-40.25M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -26.46%-48.07M | -152.62%-24.67M | 27.94%-7.34M | -7.29%-8.7M | 5.57%-38.01M | -9.77M | -3.97%-10.19M | 25.21%-8.11M | -4.80%-10.03M | -33.53%-40.25M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -26.46%-48.07M | -152.62%-24.67M | 27.94%-7.34M | -7.29%-8.7M | 5.57%-38.01M | -9.77M | -3.97%-10.19M | 25.21%-8.11M | -4.80%-10.03M | -33.53%-40.25M |
| Basic earnings per share | 39.15%-7.99 | 37.32%-2.0808 | 56.41%-1.53 | 35.69%-1.82 | -368.93%-13.13 | -3.32 | -416.18%-3.51 | -277.33%-2.83 | 10.81%-0.66 | 8.50%-2.8 |
| Diluted earnings per share | 39.15%-7.99 | 37.32%-2.0808 | 56.41%-1.53 | 35.69%-1.82 | -368.93%-13.13 | -3.32 | -416.18%-3.51 | -277.33%-2.83 | 10.81%-0.66 | 8.50%-2.8 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Trending Stocks
Discussing
January rate meeting coming! Fed's pause in rate cuts a foregone conclusion?
🎙️Discussion 1. Will the Fed press the "pause button" on rate cuts as expected? 2. Do you think President Trump's political actions will ch
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart